Stock Events

Stock Events

Fulcrum Therapeutics (FULC) Q1 2026 Earnings

24FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.31

-0.3

-0.29

-0.28

Details

Expected EPS

-0.299091

Actual EPS

-0.31

Surprise EPS

-0.01

Surprise Percent

+3.65%

Description

Fulcrum Therapeutics (FULC) has reported earnings of -0.31 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.